[Federal Register Volume 84, Number 156 (Tuesday, August 13, 2019)]
[Notices]
[Pages 40077-40079]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17282]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1112.
Project: 2020 National Survey on Drug Use and Health, Clinical
Validation Study and Redesign Field Test (OMB No. 0930-0110)--Revision
to 2019 NSDUH Collection
The National Survey on Drug Use and Health (NSDUH) is a survey of
the U.S. civilian, non-institutionalized population aged 12 years old
or older. The data are used to determine the prevalence of use of
tobacco products, alcohol, illicit substances, and illicit use of
prescription drugs. The results are used by SAMHSA, the Office of
National Drug Control Policy (ONDCP), federal government agencies, and
other organizations and researchers to establish policy, direct program
activities, and better allocate resources.
2020 NSDUH Main Study
NSDUH must be updated periodically to reflect changing substance
use and mental health issues and to continue producing current data.
For the 2020 NSDUH main study the following changes from 2019 are
planned: (1) The addition of lifetime and recency questions about
vaping anything and vaping nicotine or tobacco; the addition of
lifetime and recency questions on synthetic marijuana and synthetic
stimulants; (2) the addition of questions in concordance with the
Diagnostic and Statistical Manual of Mental Disorders (DSM), fifth
edition criteria (DSM-5) to measure the occurrence of marijuana
withdrawal symptoms, occurrence of prescription tranquilizer misuse
withdrawal symptoms and occurrence of craving for all substances; (3)
minor revisions to the marijuana marketplace module; and (4) other
minor wording changes to improve the flow of the interview, increase
respondent comprehension or to be consistent with text in other
questions.
By including these new questions in NSDUH, estimates may be
generated on the use of these substances among the general population
and allow SAMHSA to provide national-level estimates among adults and
adolescents on the
[[Page 40078]]
use of vaping, synthetic marijuana, and synthetic stimulants. In
addition, because NSDUH collects demographic, socioeconomic, and health
information about each respondent, the inclusion of these questions
would permit a more detailed understanding of factors associated with
their use.
The new questions on craving for all substances and withdrawal for
marijuana/cannabis were added to the 2020 NSDUH main study to reflect
the updated DSM-5 diagnostic criteria for substance use disorders.
Questions measuring withdrawal for tranquilizers have been added to
ensure SUD for tranquilizers is accurately assessed as well.
The marijuana marketplace module (originally dropped in the 2015
redesign questionnaire) was reinserted in the NSDUH main study
questionnaire starting in 2018 at the request of ONDCP but was
unchanged from the version previously used in the 2014 NSDUH. (This
module was not part of the NSDUH questionnaire from 2015-2017.) This
module consists of a series of questions that seek to gather data such
as the location, quantity, cost and type of marijuana being purchased
across the nation. Revisions have been made to this module for 2020 to
reflect the availability that marijuana can now be purchased from a
retail store or dispensary.
As with all NSDUH/NHSDA surveys conducted since 1999, the sample
size of the NSDUH main study for 2020 will be sufficient to permit
prevalence estimates for each of the fifty states and the District of
Columbia. (Prior to 2002, the NSDUH was referred to as the National
Household Survey on Drug Abuse (NHSDA). The total annual burden
estimate for the NSDUH main study is shown below in Table 1.
Table 1--Annualized Estimated Burden for 2020 NSDUH
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Household Screening............. 143,255 1 143,255 0.083 11,890
Interview....................... 69,007 1 69,007 1.000 69,007
Screening Verification.......... 4,348 1 4,348 0.067 291
Interview Verification.......... 10,351 1 10,351 0.067 694
-------------------------------------------------------------------------------
Total....................... 143,255 .............. 226,961 .............. 81,882
----------------------------------------------------------------------------------------------------------------
Clinical Validation Study
In addition, a Clinical Validation Study (CVS) is planned to be
embedded within the first six months of 2020 NSDUH main study data
collection to assess revisions to the substance use disorders (SUD)
module to be consistent with the DSM-5. The CVS will examine the
validity of this revised NSDUH assessment of SUD by administering
questions to adults and adolescents who will then be interviewed by
clinical interviewers (who are blinded to the NSDUH main study
responses) and classified as having or not having substance use
disorders based on past year DSM-5 disorders, as assessed by the
Structured Clinical Interview for DSM-5 (SCID-5)
During CVS data collection from January through June 2020,
approximately 1,500 NSDUH main study interview respondents will be
selected for a follow-up clinical interview at the end of the main
study interview in order to produce a final sample size of
approximately 826 CVS respondents. These follow-up clinical interviews
will be conducted via telephone using the SCID-5 within two to four
weeks following the NSDUH main study interview.
Many of the procedures and protocols planned for inclusion in this
CVS are based upon those previously employed as part of the 2018
National Mental Health Study (approved under OMB No. 0930-0380) and the
2008-2012 NSDUH Mental Health Surveillance Study (approved as an add-on
to NSDUH under OMB No. 0930-0110).
Also, to complete training prior to CVS data collection, each
clinical interviewer candidate hired must successfully administer the
follow-up clinical interview with a volunteer respondent. These 70
certification interviews will be administered in the same manner as CVS
follow-up clinical interviews.
The total annual burden estimate for the CVS is shown below in
Table 2.
Table 2--Annualized Estimated Burden for 2020 NSDUH CVS
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Follow-Up Clinical Interviews... 800 1 800 0.83 664
Follow-Up Clinical 70 1 70 0.83 58
Certifications.................
-------------------------------------------------------------------------------
Total....................... 870 .............. 870 .............. 722
----------------------------------------------------------------------------------------------------------------
Redesign Field Test
Also, as part of SAMHSA's ongoing effort to ensure NSDUH continues
producing current and accurate data, a Redesign Field Test (FT) is
planned from August through November 2020 to assess potential revisions
to the NSDUH main study questionnaire. These revisions are designed to
address changing policy and research data needs; in addition,
modifications to associated survey materials and methods are designed
to improve the quality of estimates and the efficiency of data
collection. Planned FT modifications include changes to respondent
incentives, respondent materials, the household screening
questionnaire, the interview questionnaire, and other data collection
methods.
The FT is essential for providing a thorough examination of these
planned changes prior to their deployment on the NSDUH main study to
determine potential impact across operational and
[[Page 40079]]
substantive domains, including effects on data quality (as measured by
outcomes such as unit nonresponse, item nonresponse, and survey
responses), questionnaire timing, data collection efficiency, and
possible differences in reporting of substance use or mental health
items.
During FT data collection from August through November 2020,
conducted separately from ongoing 2020 NSDUH main study data collection
at that time, screenings will be completed with approximately 8,110
English-speaking respondents in the contiguous United States. (Alaska
and Hawaii are excluded from the FT to control study costs.) From those
screenings, approximately 4,000 respondents, as representatives of the
civilian, noninstitutional population aged 12 years old or older, are
expected to complete a FT interview using the revised questionnaire and
materials.
For the NSDUH FT screening, revisions may include: (1) A revised
roster structure; (2) various wording edits to improve respondent
comprehension and flow; (3) the use of revised materials, such as the
lead letter, study description and question & answer brochure; (4) a
conditional test of a $5 screening incentive to assess impact on
response rates; and (5) the inclusion of two outcome questions on past
month alcohol and past month cigarette use at the end of the screening
to assess nonresponse bias from the screening incentive.
For the NSDUH FT interview, revisions may include: (1) A
conditional test of a $50 interview incentive to assess impact on
response rates; (2) revisions to the DSM-5-based SUD module as a result
of prior testing in the CVS; (3) the inclusion of new modules on
substance use treatment and mental health service utilization; (4) the
addition of new and/or revised questions on a variety of items such as
Electronic Nicotine Delivery Systems (ENDS), synthetic drugs, pain and
sleep, vaping and needle use, and criminal justice; (5) the addition of
measures of adolescent psychological distress and/or impairment; (6)
the expansion of suicide items; and (7) other general questionnaire
revisions such as clarifying wording and terminology, reordering for
improved question flow, formatting changes, removal of questions with
low prevalence rates, and other minor updates and revisions.
The total annual burden estimate for the FT is shown below in Table
3.
Table 3--Annualized Estimated Burden for Redesign Field Test
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Household Screening............. 8,110 1 8,110 0.083 673
Interview....................... 4,000 1 4,000 1.000 4,000
Screening Verification.......... 246 1 246 0.067 17
Interview Verification.......... 600 1 600 0.067 40
-------------------------------------------------------------------------------
Total....................... 8,110 .............. 12,596 .............. 4,730
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent by September 12, 2019 to the
SAMHSA Desk Officer at the Office of Information and Regulatory
Affairs, Office of Management and Budget (OMB). To ensure timely
receipt of comments, and to avoid potential delays in OMB's receipt and
processing of mail sent through the U.S. Postal Service, commenters are
encouraged to submit their comments to OMB via email to:
[email protected]. Although commenters are encouraged to send
their comments via email, commenters may also fax their comments to:
202-395-7285. Commenters may also mail them to: Office of Management
and Budget, Office of Information and Regulatory Affairs, New Executive
Office Building, Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2019-17282 Filed 8-12-19; 8:45 am]
BILLING CODE 4162-20-P